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Introduction
The sympathetic nervous system regulates cardiovascular func-
tion through innervation of the heart, kidney, and blood vessels 
throughout the body. Sympathetic neurons deliver catechol-
amines to target tissues, and the adrenal gland releases catechol-
amines into circulating blood. Although sympathetic nerves are 
the principal source of catecholamines for cardiac adrenergic 
receptors (ARs), little is known about the cell–cell interactions 
between sympathetic nerves and cardiac myocytes.
β1 and β2ARs, which are members of the G protein–
  coupled receptor (GPCR) family, form the interface between 
the sympathetic nervous system and cardiac muscle. However, 
the function and distribution of specifi  c βAR subtypes at car-
diac sympathetic synapses have not been addressed. These 
  homologous receptors play distinct roles in regulating normal 
cardiovascular physiology (Rohrer et al., 1999), and there is a 
growing body of evidence that they play opposing roles in the 
pathogenesis of heart failure (Patterson et al., 2004; Bernstein 
et al., 2005; Zheng et al., 2005). A better understanding of 
the subtype-specifi  c signaling of β1 and β2ARs in cardiac myo-
cytes in response to sympathetic nervous system activation 
could have implications for the prevention and treatment of 
heart failure.
β1 and β2ARs are highly homologous both structurally 
and functionally. They share 52% identity overall and 76% 
identity in the transmembrane domains. However, studies in 
both neonatal and adult cardiac myocytes provide compelling 
evidence that β1 and β2ARs signal through distinct pathways 
(Xiang and Kobilka, 2003b; Xiao et al., 2004). In neonatal myo-
cytes, activated β1AR couples only to Gs (guanine nucleotide–
binding protein that stimulates adenylyl cyclase) and leads to 
a PKA-dependent increase in the contraction rate. In contrast, 
 activated  β2AR undergoes sequential coupling to Gs and Gi 
(guanine nucleotide–binding protein that inhibits adenylyl 
  cyclase), having a biphasic effect on the contraction rate that is 
independent of PKA activation (Devic et al., 2001).
Functional differences between β1 and β2ARs in cardiac 
myocytes can be attributed to subtype-specifi  c targeting to dif-
ferent signaling compartments in the myocyte plasma mem-
brane (Xiang et al., 2002). Activated β2ARs undergo robust 
endocytosis, whereas activated β1ARs remain at the plasma 
membrane (Xiang et al., 2002). In neonatal cardiac myocytes, 
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he sympathetic nervous system regulates cardiac 
function through the activation of adrenergic recep-
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stimulation of neuronal activity. The results indicate 
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diac myocytes at sites of contact with sympathetic neu-
rons and that these domains are likely to play a role in 
the subtype-speciﬁ  c regulation of cardiac function by β1 
and β2ARs in vivo.
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endocytosis and recycling are both required for the switch 
in β2AR coupling from Gs to Gi (Devic et al., 2001; Shenoy 
and Lefkowitz, 2003; Xiang and Kobilka, 2003b). β2ARs are 
  predominantly concentrated in caveolar structures, whereas 
β1ARs are mainly distributed in the noncaveolar membrane 
(Rybin et al., 2000). The cAMP phosphodiesterase PDE4D 
  regulates signaling by the β2AR but has no detectable effect 
on β1AR signaling, suggesting that this phosphodiesterase iso-
form might be a component of the β2AR signaling complex 
(Xiang et al., 2005). These observations suggest that distinct 
signaling domains exist in cardiac myocytes to conduct β1 and 
β2AR signaling.
The heart is richly innervated by sympathetic neurons, 
which are the principal source of catecholamines for cardiac 
ARs (Armour, 1994). As β1 and β2ARs are the primary sym-
pathetic receptors in the heart, their distribution and function 
could be infl  uenced by the sympathetic innervation of cardiac 
myocytes. Synapses in the central nervous system and neuromus-
cular junctions are formed by coordinated assembly and tight 
attachment of pre- and postsynaptic specializations (Sanes and 
Lichtman, 2001). At the site of contact, the postsynaptic plasma 
membrane develops into a specialized zone that contains accu-
mulations of neurotransmitter receptors, channels, and anchoring 
and signaling molecules (Sheng and Kim, 2002). This co-
localization is thought to provide a fast and effi  cient response 
to released neurotransmitter. Accumulation of receptors at the 
postsynaptic sites is regulated by synaptogenesis, whereas the 
dynamic behavior of receptors, such as endocytosis, exocytosis, 
and lateral movement, is regulated by activity-dependent cues 
(Misgeld et al., 2002; Bredt and Nicoll, 2003; Park et al., 2004; 
Perez-Otano and Ehlers, 2005).
In this study, we report the fi  rst detailed analysis of the 
organization of signaling molecules at the site of innervation of 
cardiac myocytes by sympathetic neurons. We demonstrate that 
sympathetic ganglion neurons (SGNs) regulate the contraction 
rate of cultured myocytes and provide evidence that sympa-
thetic innervation infl  uences the structure of the myocyte mem-
brane and the organization and distribution of β1 and β2AR 
signaling compartments. Cardiac myocytes induce presynaptic 
differentiation in contacting axons; synaptic vesicles accumu-
late at the sites of contact as delineated by synapsin I. On the 
postsynaptic side, the myocyte membrane develops into spe-
cialized zones that surround contacting axons and contain ac-
cumulations of the scaffold proteins SAP97 and AKAP79/150. 
In contrast, staining for caveolin-3, which is a marker of signaling 
caveolae microdomains in cardiac myocytes, is diminished 
at the sites of contact. The cardiac myocyte membranes are 
linked to contacting neurons by cadherin–catenin complexes. 
We have found striking differences in the traffi  cking of β1 
and  β2AR-expressed myocytes that have been innervated 
by cultured sympathetic neurons. β1ARs accumulate at the 
sy naptic  zones,  whereas  β2ARs undergo local internalization 
from the synaptic sites in a neuronal activity-dependent 
manner. The subtype-specifi  c differences in the localization of 
β1 and β2AR at sympathetic synapses likely contribute to the 
  regulation of cardiac performance by the sympathetic nervous 
system in vivo.
Results
SGNs form functional connections 
with cardiac myocytes in vitro
To determine whether SGNs form functional connections with 
neonatal cardiac myocytes in vitro, we stimulated the cardiac 
myocyte contraction rate through the activation of neurons. The 
sympathetic cervical (autonomic) ganglia contain predomi-
nantly neuronal nicotinic acetylcholine receptors (nAChRs), 
which play a central role in neural transmission in the auto-
nomic nervous system. In vivo, the transmitter released from 
the preganglionic axon terminals is primarily acetylcholine, 
which depolarizes postsynaptic neurons by the activation of 
nAChR (Haass and Kubler, 1997; Lechner et al., 2003). The ac-
tivation of nAChR with nicotine causes the depolarization of 
SGN, which, in turn, triggers neurotransmitter release. It has 
been shown that nicotine-induced changes in the heart rate are 
associated with an increase in plasma catecholamine concentra-
tions, and they are attenuated by βAR blockade, indicating that 
the increase in heart rate is mediated by βARs (Haass and 
Kubler, 1997). Nicotine applied to cardiac myocytes in the ab-
sence of neurons did not produce any changes in the contraction 
rate (unpublished data).
Myocytes were cocultured on the same coverslip with 
SGN or on separate coverslips (Fig. 1). SGNs were stimulated 
with 1 μM nicotine. This relatively low concentration of nico-
tine was used to minimize the release of catecholamines into the 
media because it has been shown that nicotine concentrations 
Figure 1.  Stimulation of SGNs by nicotine results in an increase in the 
beating rate of contacting myocytes. Myocytes and SGNs were cocultured 
on the same coverslip or on separate coverslips in the same culture dish. 
The change in myocyte contraction rate was monitored by video micros-
copy before and after the stimulation of SGNs with 1 μM nicotine tartrate. 
The data are the mean +/− SEM (error bars) of three experiments. Two-
way analysis of variance demonstrated that there was a signiﬁ  cantly 
greater increase in the beat rate of myocytes cocultured on the same cover-
slip with SGNs compared with myocytes and neurons cultured on separate 
coverslips (P < 0.0001). The increase of the beat rate over baseline was 
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over 3 μM can lead to an accumulation of noradrenaline in the 
media of cultured SGNs (Norenberg et al., 2001). We observed 
an increase ( 2.5-fold) in the contraction rate of cardiac myo-
cytes cultured on the came coverslip with SGN (Fig. 1). The ef-
fect was much lower when myocytes and neurons were placed 
on different coverslips and, therefore, could not form connec-
tions with each other. Thus, stimulation of the myocyte contrac-
tion rate by activated SGNs requires that neurons form contacts 
with myocytes.
Formation of specialized cell–cell contacts 
between cardiac myocytes and SGNs
Accumulation of synapsin I in axons that   contact 
myocytes. Synaptogenesis involves the organization of spe-
cialized signaling complexes at sites of cell–cell contact that are 
designed to rapidly and effi  ciently relay signals from one cell to 
another (Garner et al., 2002). To test whether cardiac myocytes 
induce the formation of active presynaptic zones in contacting 
axons, we immunostained the cocultures with an antibody to 
synapsin I, a peripheral membrane protein of synaptic vesicles 
(Scheiffele et al., 2000). We observed the formation of synapsin I 
puncta in axons contacting cardiac myocytes, which suggests 
that synaptic vesicles cluster at those sites (Fig. 2, A and C). 
The accumulation of synapsin I increased with the time of 
  coculturing cardiac myocytes and SGNs (unpublished data). In 
contrast, the accumulation of synapsin I was much less pro-
nounced in neurons that contacted cardiac fi  broblasts stained 
for fi   bronectin (Fig. 2, B and C). Particularly notable was 
the difference in the number of large (>1 μM) puncta of syn-
apsin I, which was greater in myocytes compared with fi  bro-
blasts. This suggests that neurons form specialized contacts 
with myocytes.
Synaptic vesicles undergo activity-dependent 
recycling at the sites of contact of cardiac 
  myocytes and SGNs. Synapsin accumulation may not 
necessarily mark functional sites of transmitter release. To 
  examine synaptic activity, we monitored activity-dependent 
  internalization of an antibody to the luminal domain of synap-
totagmin, a method that has been shown to mark the sites of 
synaptic vesicle endocytosis (Kraszewski et al., 1995). Synap-
totagmin antibody was added to cocultures of myocytes and 
SGNs, and antibody internalization was stimulated by the addi-
tion of 500 μM nicotine. Cultures were then fi  xed and costained 
for synapsin I (Fig. 3). Synaptotagmin antibody internalization 
colocalizes with synapsin I throughout the axon. The uptake 
was completely abolished in Ca
2+-free media. Therefore, synaptic 
vesicles undergo activity-dependent recycling at the sites of 
contact of SGNs and cardiac myocytes.
We also performed analysis of the activity-dependent de-
staining of FM1-43 dye. The fl  uorescent styryl dye FM1-43 is 
taken up by synaptic vesicles in an activity-dependent manner 
(Betz and Bewick, 1992; Ryan et al., 1993; Zakharenko et al., 
2001). Cocultures were loaded with FM1-43 in the presence of 
500 μM nicotine for 5 min and were washed to remove back-
ground staining (Fig. S1 A, available at http://www.jcb.org/cgi/
content/full/jcb.200604167/DC1). During a second round of 
nicotine stimulation, the fl  uorescence intensity of labeled puncta 
rapidly diminished by  80%, refl  ecting exocytosis of the dye 
from synaptic vesicles (Fig. S1, B and C). Therefore, synaptic 
vesicles undergo activity-dependent recycling at the sites of 
contact of SGNs and cardiac myocytes. As with the antibody to 
the luminal domain of synaptotagmin, FM1-43 uptake is punc-
tate and is not uniformly distributed along the axon. Therefore, 
it is likely that release occurs at closely spaced but discrete sites 
along the entire axonal contact.
Exclusion of caveolin-3 at sites of contact 
between myocytes and SGNs.  Caveolin-3 is ex-
pressed in cardiac myocytes and marks specialized membrane 
microdomains known as caveolae; thus, we have used caveolin-3 
as a cardiac myocyte-specifi  c marker. Previous studies showed 
that β2ARs are associated with caveolin-3 in the neonatal car-
diac myocyte and that this localization may be important 
for physiologic function (Devic et al., 2001; Xiang et al., 2002). 
Interestingly, we observed the exclusion of caveolin-3 from mem-
branes of cardiac myocytes at sites of contact with neurons in 
Figure 2.  Accumulation of synapsin at contact sites of SGNs and cardiac 
myocytes. (A) SGNs and cardiac myocytes at 9 d in coculture immuno-
stained with an antibody to synapsin I (green) and caveolin-3 (red). (B) SGNs 
and cardiac ﬁ   broblasts at 9 d in coculture stained with antibody to 
  synapsin I (green) and ﬁ  bronectin (red). (C) Quantitative comparison of 
synapsin puncta formation in cocultures of SGNs and cardiac myocytes 
versus SGNs and cardiac ﬁ  broblasts. The number of puncta on 10 cells 
averaged over three experiments. The approximate sizes of synapsin I 
puncta were as follows: large, >1.0 μm; medium, 0.5–1.0 μm; small, 
<0.5 μm (n = 15 cells). A t test was used to determine signiﬁ  cance 
(**, P < 0.01 for medium puncta; ***, P < 0.001 for large puncta). Error 
bars represent SEM.JCB • VOLUME 176 • NUMBER 4 • 2007  524
 60% of cells examined by two-photon microscopy (Fig. 4). The 
loss of caveolin-3 is not limited to sites adjacent to synapsin I ac-
cumulation but extends through the length of the axon. We did 
not observe an increase in the removal of caveolin-3 after stimu-
lation of the cocultures with nicotine, suggesting that caveolin-3 
may be excluded from the myocyte membrane upon the forma-
tion of contacts with SGN. Caveolin marks plasma membrane 
signaling domains that recruit certain lipid-modifi  ed membrane 
proteins (including receptors, G proteins, and tyrosine kinases) 
while excluding other proteins and lipid components (Cohen 
et al., 2004). Removal of caveolin-3 from the contact sites of 
myocytes and neurons indicates a reorganization of signaling 
  microdomains in the plasma membrane of cardiac myocytes in 
contact with SGN axons.
Cadherin–catenin complexes form at the 
sites of contact between cardiac myocytes and 
SGNs.  Cadherins are calcium-dependent homophilic cell 
  adhesion molecules that maintain the integrity of cell–cell 
  junctions and promote the stability of synapses by linking 
pre- and postsynaptic membranes. Extracellular domains of 
cadherins interact directly to help hold the membranes of two 
cells together. The requirement of mechanical stability is most 
clear at the neuromuscular junction, which is maintained in 
the face of constant mechanical stress from muscle contraction 
(Yamagata et al., 2003). We observed puncta of pancadherin 
immunostaining on the surface of cardiac myocytes localized 
along traces of axons, which were identifi  ed by staining with an 
antibody to tyrosine hydroxylase (Fig. 5 A). As shown on a two-
photon image (Fig. 5 C), synapsin I puncta were often observed 
overlapping cadherin immunostaining (frequency of 74 ± 15% 
[SEM]). However, cadherin puncta are more abundant, and the 
majority of cadherin staining does not localize with synapsin I 
puncta. Nevertheless, cadherin puncta are not observed in myo-
cytes cultured in the absence of SGN (unpublished data), sug-
gesting that these puncta represent contacts between SGN fi  bers 
and myocytes. The fact that not all cadherin staining localizes 
with synapsin I puncta suggests that not all contacts between 
SGNs and myocytes are sites of synaptic activity.
Cadherins are known to form complexes with β-catenin, 
which, in turn, associates with α-catenin and the actin cytoskeleton. 
Immunostaining of cocultures for synapsin I and β-catenin 
  revealed that the pattern of staining for β-catenin (Fig. 6) was 
very similar to the pattern of staining for pancadherin (Fig. 5), 
and the majority of synapsin I puncta colocalized with β-catenin 
(Fig. 6, C–E). Our culture results predict that catenin–cadherin 
complexes may be important for stabilizing interactions between 
myocytes and neurons in vivo. Therefore, we examined the 
Figure 3.  Visualization of active synaptic sites in a coculture of cardiac 
myocytes and SGNs by uptake of an antibody to the luminal domain of 
synaptotagmin. A coculture of cardiac myocytes and SGNs was incubated 
with serum-free media containing 500 μM nicotine and 10 μg/ml rabbit 
polyclonal antibody to the luminal domain of synaptotagmin for 15 min fol-
lowed by rinsing, ﬁ  xation, and immunostaining with a mouse monoclonal 
antibody to synapsin I. (A) Brightﬁ  eld image of the coculture. (B) Immuno-
staining for synaptotagmin (green). (C) Immunostaining for synapsin I (red). 
(D) Merged image of B and C.
Figure 4.  Caveolin-3 is diminished at sites of contact between cardiac 
myocytes and SGNs. (A) Cardiac myocytes and SGNs at 9 d in coculture 
were immunostained with antibodies for caveolin-3 (red) and thyrosine 
  hydroxylase (green) and were imaged by two-photon microscopy. (B) 3D 
reconstruction of an enlarged region of the boxed image in A. (C) X-z cross 
section of the 3D reconstruction.SYMPATHETIC SYNAPSES IN CARDIAC MYOCYTES • SHCHERBAKOVA ET AL. 525
 distribution  of  β-catenin relative to synapsin I in intact ventricu-
lar muscle from the mouse heart. Tissue sections were stained 
with antibodies to synapsin I and β-catenin and were examined 
by two-photon microcopy. Consistent with our culture results, 
we observed the accumulation of β-catenin surrounding contact-
ing axons (Fig. S2, available at http://www.jcb.org/cgi/content/
full/jcb.200604167/DC1). These results suggest that cadherin–
catenin complexes may be involved in stabilizing interactions 
between SGNs and myocytes in vivo; however, we have no 
  evidence that they play a direct role in synaptic function.
Subtype-speciﬁ  c targeting and trafﬁ  cking 
of 𝗃1 and 𝗃2ARs at sympathetic synapses 
in cardiac myocytes
Collectively, the aforementioned data demonstrate that in co-
culture, cardiac myocytes and SGNs form specialized functional 
connections. Catecholamines (epinephrine and predominantly 
norepinephrine) are the major neurotransmitters released from 
SGN (Esler and Kaye, 2000), and βARs are the principal cate-
cholamine receptors in cardiac myocytes. Therefore, we exam-
ined how interactions with SGN fi  bers and neurotransmission 
affect the localization of βARs in myocytes. Currently available 
antibodies are not adequate to detect endogenous βARs in car-
diac myocytes. Thus, to visualize β1 and β2ARs in cardiac myo-
cytes, we expressed FLAG-tagged β2AR or HA-tagged β1AR 
via recombinant adenovirus in cocultures. We have previously 
shown that the functions of epitope-tagged β1 and β2ARs ex-
pressed in β1AR/β2AR knockout (KO) myocytes are indistin-
guishable from endogenous receptors in β2AR KO and β1AR 
KO myocytes, respectively (Xiang et al., 2002; Xiang and Kobilka, 
2003a). We took advantage of the fact that SGNs at 7–10 d in 
culture are highly resistant to adenovirus infection; therefore, 
we were able to express the receptors predominantly in car-
diac myocytes and analyze the distribution of βARs relative 
to   synaptic sites. To address activity-dependent events in co-
cultures, we stimulated neurotransmission through activation of 
the nAChRs of SGN with 500 μM nicotine.
𝗃2ARs are removed from synaptic sites 
  after SGN stimulation. We observed no changes in the 
distribution of FLAG-tagged β2AR in the majority of cardiac 
myocytes in contact with unstimulated SGNs (Fig. 7, A and B).
However, in a few cells per coverslip ( 1–2%), we observed 
a decrease in FLAG antibody staining at sites of SGN–myocyte 
contacts (Fig. 7, C and D). Nicotine induced the removal of 
FLAG-tagged β2ARs from the surface of cardiac myocytes at the 
sites of contact with SGNs (Fig. 7, E–H). This effect was ob-
served in 72 ± 6% of myocytes in nicotine-stimulated cocultures. 
β2AR removal was observed in only 15 ± 2% of myocytes from 
nicotine-stimulated cultures pretreated with the βAR antagonist 
alprenolol (Fig. S3, available at http://www.jcb.org/cgi/content/
full/jcb.200604167/DC1), indicating that the traffi  cking of β2ARs 
requires activation of the receptor. We observed the effect as 
fast as 5 min after the treatment, which is consistent with the 
time course of the activation of cardiac myocytes through neu-
rons described earlier (Fig. 1). The time course of the removal of 
β2AR is also consistent with the time course of β2AR activation 
and internalization (von Zastrow and Kobilka, 1992). Thus, we 
concluded that β2ARs are locally internalized at the sites of con-
tacts, and this redistribution is regulated by neuronal activity.
Quantitation of β2AR staining intensity revealed a signifi  -
cant decrease in intensity along the trace of axons marked by 
Figure 5.  Cadherins accumulate at sites of contact between cardiac 
  myocytes and SGNs. (A) Cardiac myocytes and SGNs at 5 d in coculture 
were immunostained for tyrosine hydroxylase (green) and pancadherin 
(red). (B) Same image as in A showing only pancadherin immunostaining. 
(C) Cardiac myocytes and SGNs at 5 d in coculture were immunostained 
for synapsin I (green) and pancadherin (red). (D) Same image as in 
C showing only pancadherin immunostaining.
Figure 6.  𝗃-catenin accumulation at sites of contact between cardiac myo-
cytes and SGNs. (A) Cardiac myocytes were cocultured with SGNs for 2 d, 
immunostained for β-catenin (red) and synapsin I (green), and imaged by two-
photon microscopy. (B) Same image as in A showing only β-catenin immuno-
staining. (C–E) 3D-reconstructed enlarged fragment from A. 1 U = 1.4 μM.JCB • VOLUME 176 • NUMBER 4 • 2007  526
synapsin I staining compared with areas of the myocyte not in 
contact with axons (P < 0.05; Fig. 7 G). We also found that 
β2AR staining intensity was signifi  cantly lower under synapsin I 
staining puncta compared with regions along SGN axons that 
lie between synapsin I puncta (P < 0.05; Fig. 7 H). These data 
suggest that the release of transmitter is not uniform along the 
contacting axons and are consistent with antisynaptotagmin anti-
body and FM1-43 uptake experiments (Figs. 3 and S1).
𝗃1ARs are localized to zones of myocyte-
SGN contact. The pattern of β1AR distribution is strikingly 
different from that of the β2AR (Fig. 8, A–G). In cocultures 
immunostained for synapsin I and HA-tagged β1AR, we ob-
served approximately two times more staining for HA-tagged 
β1ARs in myocyte membrane associated with axonal traces 
compared with myocyte membrane not associated with axons 
(Fig. 8 H). The immunostaining pattern for HA-tagged β1ARs 
mirrors the shape of overlying axons (Fig. 8, A–D), and the 
  maximum accumulation of the receptors often surrounds the sites 
of synapsin I accumulation, which are presumably the sites of 
highest neurotransmission activity. The characteristic zones 
highlighted by immunostaining for HA-tagged β1ARs and sur-
rounding traces of axons on the surface of myocytes appear as 
soon as the second day of coculture and become much more pro-
nounced in mature cocultures (10 d; unpublished data). Interest-
ingly, using 3D reconstructions from two-photon z sections, we 
observe an invagination of the myocyte membrane at the point of 
contact with an SGN (Fig. 8, E–G; and Video 1, available at http://
www.jcb.org/cgi/content/full/jcb.200604167/DC1). This suggests 
that cardiac myocytes change their morphology to establish func-
tional contacts with SGNs. We did not observe an effect of nico-
tine or β blockers on the distribution of HA-tagged β1AR in 
cardiac myocytes. Thus, our data indicate that β1ARs are stable 
residents at sympathetic synapses, whereas the β2ARs undergo 
dynamic traffi  cking events regulated by neuronal activity.
Disruption of the PDZ domain of 𝗃1AR did 
not affect localization to zones of myocyte–SGN 
contact. We have previously observed that disruption of the 
PDZ-binding motif of the C terminus of β1AR has a dramatic 
 effect on both traffi  cking and signaling in cardiac myocytes.  Unlike 
wild-type β1AR, β1AR lacking a PDZ-binding motif (β1AR-PDZ) 
is able to undergo agonist-induced   internalization and can couple 
to both Gs and Gi. Thus, PDZ domain interactions are important 
for normal β1AR function. Surprisingly, localization of β1AR-
PDZ relative to sympathetic synapses was indistinguishable from 
wild-type β1AR (Fig. 8, C and D), suggesting that some other 
domains of β1AR are primarily responsible for localization of 
the receptor relative to the synapse.
Accumulation of scaffold molecules 
at zones of myocyte–SGN contact
As shown in Fig. 8 (E–G), there is an invagination of the myo-
cyte membrane at sites of contact between cardiac myocytes 
and SGN cells. This bears a resemblance to the structure of neuro-
muscular junctions in skeletal muscle. Moreover, the subtype-
specifi  c localization of β1 and β2ARs and the exclusion of 
caveolin-3 suggest that sites of contact between myocytes and 
SGNs are specialized signaling domains. Therefore, we looked 
for other molecules that have been associated with synapses and 
might be involved in the traffi  cking, regulation, and signaling of 
β1AR. Members of the SAP90/PSD-95 subfamily of  membrane-
associated guanylate kinase homologues have   recently emerged 
as important players in the molecular organization of synapses 
Figure 7.  𝗃2AR is depleted at synaptic sites after stimulation of neuronal 
activity. Cardiac myocytes were cocultured with SGNs for 6 d, infected 
with recombinant adenovirus expressing FLAG-tagged β2AR, and cultured 
for an additional 48–72 h before immunostaining for FLAG (red) and 
  synapsin I (green). (A and B) Nonstimulated cultures. (C and D) Example 
of β2AR removal by spontaneous neuronal activity in nonstimulated coculture. 
(E and F) Cocultures that were stimulated with 500 μM nicotine for 
5 min. (G) Comparison of the ﬂ  uorescence intensity of immunostaining for 
FLAG-tagged β2AR in synaptic and extrasynaptic areas after the stimula-
tion of coculture with nicotine. The mean ﬂ  uorescence intensity for the red 
channel representing immunostaining for FLAG-tagged β2AR was meas-
ured in areas where the green channel ﬂ  uorescence (immunostaining for 
synapsin I) was selected as a criterion. Next, we excluded the area se-
lected and measured the ﬂ  uorescence for the red channel at extrasynaptic 
regions. Data were collected from 10 images obtained in three experiments. 
(H) Comparison of the ﬂ   uorescence intensity of immunostaining for 
FLAG-tagged β2AR beneath synapsin I puncta and between synapsin I 
puncta along the axon after the stimulation of coculture with nicotine. 
To compare the ﬂ   uorescence intensity of β2AR staining in the areas of 
  synapsin I accumulation with areas along axons between synapsin I 
puncta, we used the Wizard tool of the Volocity program to select regions 
of interest. Data were obtained from three images using six different pairs 
of the region of interest on each image. (G and H) Measurements were 
performed in arbitrary units of the direct scale. Comparisons were per-
formed with a t test. Statistical signiﬁ  cance was set as P < 0.05. **, P < 
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in neurons (Funke et al., 2005). In contrast to most other 
 membrane-associated guanylate kinase homologues, the synapse -
associated protein SAP97 is also expressed in nonneuronal 
 tissues, including cardiac myocytes (Muller et al., 1995). Indeed, 
we have found that SAP97 localized to the zones of contact 
between myocytes and SGNs (Fig. S4, available at http://www
.jcb.org/cgi/content/full/jcb.200604167/DC1). We also examined 
the localization of SAP97 in intact ventricular muscle from the 
mouse heart. Tissue sections were stained for synapsin I and 
SAP97 and examined by two-photon microcopy. Consistent 
with our culture results, we observed the accumulation of SAP97 
surrounding contacting axons (Fig. S5).
The intensity of immunostaining for SAP97 associated 
with SGN was increased after 90 min of stimulation with nico-
tine in cocultures in which β1AR was overexpressed in cardiac 
myocytes (Fig. S4). We conducted a blind analysis of the size 
and intensity of SAP97-positive spots (puncta). Cocultures that 
were stimulated by nicotine exhibited an increase in the area 
and intensity of SAP97-positive puncta when compared with 
the controls (Fig. S4, C and D). An increase in the size of 
SAP97-positive puncta was also observed in wild-type cardiac 
myocytes not expressing exogenous β1AR, but the increase was 
not statistically signifi  cant. SAP97 was observed at the synaptic 
sites in β1AR KO and β1/β2AR KO myocytes, but we did not 
detect an increase in the intensity of immunostaining for SAP97 
after nicotine stimulation. The results suggest that β1AR sig-
naling can modulate SAP97 accumulation at synapses. Two-
photon imaging revealed a partial overlap in immunostaining 
for β1AR and SAP97 in cardiac myocytes (Fig. 9). Thus, the 
proteins may function within the same signaling compartment 
but may not directly interact.
The postsynaptic density in neuronal synapses and post-
synaptic membranes in neuromuscular junctions are known to 
contain accumulations of receptors, channels, and anchoring 
and signaling molecules. This colocalization is thought to pro-
vide a fast and effi  cient response to released neurotransmitter 
as well as facilitate retrograde signaling from targeting cells to 
the contacting neuron. PKA and phosphatase 2B anchored by 
AKAP79 are known to be associated with postsynaptic density 
in neurons (Dell’Acqua et al., 2002; Bauman et al., 2004), and 
PKA and D-AKAP are also found in and around the neuromus-
cular junction (Perkins et al., 2001). By analogy with this, we 
have found the accumulation of AKAP79/150 (mouse ortho-
logue of AKAP79) to the zones of contact between cardiac 
  myocytes and SGNs (Fig. 10, A and B). When we expressed 
HA-tagged β1AR in cardiac myocytes in a coculture and immuno-
stained the cocultures for AKAP79/150 and HA, we observed 
both proteins at the zones of contact. Although there may be 
some overlap, the pattern of staining appears to be different 
(Fig. 10, C and D), suggesting that these proteins may not inter-
act directly. Nevertheless, their proximity in the sympathetic 
synapse suggests that AKAP79/150 could play a role in β1AR 
signaling. In contrast, two other PDZ scaffold proteins known 
to localize to cell–cell contacts, MAGI-3 and MUPP1, were not 
detected at sites of myocyte–SGN contact (unpublished data).
Discussion
The sympathetic nervous system plays a central role in the 
  cardiovascular response to acute stress by increasing heart rate 
and contractility. However, chronic sympathetic nervous system 
hyperactivity has been implicated in the pathogenesis of heart 
Figure 8.  𝗃1ARs accumulate at sites of contact 
  between SGNs and cardiac myocytes. (A and B) 
  Cardiac myocytes were cocultured with SGNs for 6 d, 
infected with recombinant adenovirus expressing 
HA-tagged β1AR, and cultured for an additional 24 h 
before immunostaining for HA (red) and synapsin I 
(green). (C and D) Cardiac myocytes were cocul-
tured with SGNs for 6 d, infected with recombinant 
adenovirus expressing HA-tagged β1AR-PDZ, and 
cultured for an additional 24 h before immunostaining 
for HA (red) and synapsin I (green). Insets show en-
largements of the images outlined by dotted white 
lines. (E–G) X-z cross section of the 3D reconstruction 
of a two-photon image of the site of contact between 
a cardiac myocyte expressing HA-tagged β1AR and 
an SGN immunostained for HA (red) and synapsin I 
(green). (H) Histogram of the ﬂ  uorescence intensity 
along the red line in B. The red and blue lines indi-
cate the boundaries of the axon bundle, which are 
represented by red and blue circles in B. (bottom) 
Comparison of the accumulation of β1AR in the zones 
of contact with SGNs. The histograms of ﬂ  uorescence 
intensity of the original LSM510 ﬁ  les for ﬁ  ve different 
images were used to quantify the accumulation of 
β1AR in the zones of contact with SGNs. The mean 
ﬂ  uorescence intensity in the areas inside and outside 
the zones of contact along the selected straight line 
crossing a zone of contact was quantiﬁ  ed (H; two 
zones from each image). Measurements were per-
formed in arbitrary units of the direct scale. Statistic 
comparisons were performed with a t test. Error bars 
represent SEM. ***, P < 0.001.JCB • VOLUME 176 • NUMBER 4 • 2007  528
failure (Mann and Bristow, 2005). The assembly, development, 
and function of synapses between neurons in the central nervous 
system (Sudhof, 2001) and neuromuscular junctions of skeletal 
muscle (Sanes and Lichtman, 1999; Goda and Davis, 2003) have 
been characterized in depth. Much less is known about sympa-
thetic synapses. In this study, we provide evidence that contact 
between SGN axons and myocytes leads to the formation of spe-
cialized zones in the myocyte membrane. These zones are char-
acterized by the accumulation of β1ARs as well as adhesion and 
scaffold molecules and the exclusion of caveolin-3. The observa-
tion that there is an activity-dependent loss of β2AR staining at 
regions of synapsin I accumulation suggests that synaptogenesis 
takes place within these specialized SGN–myocyte contacts.
Sympathetic innervation in culture 
is predominantly adrenergic
Previous studies of rat cardiac myocytes cultured together with 
dissociated rat superior cervical ganglia show that these neu-
rons can differentiate into adrenergic neurons and cholinergic 
neurons and that most cultured neurons secreted both neuro-
transmitters, with at least some of the acetylcholine release be-
ing at autosynapses (Furshpan et al., 1986; Potter et al., 1986). 
It has been shown that brain-derived neurotrophic factor alters 
the release properties of these cultured neurons from excitatory 
(adrenergic) to inhibitory (cholinergic; Yang et al., 2002). 
Although we observed that most cultured SGNs were positive 
for both cholinergic and adrenergic markers (unpublished data) 
in our cultures, our functional studies indicate that the neurons 
in contact with cardiac myocytes are predominantly adrenergic, 
as stimulation led to a robust increase in the intrinsic rate of 
spontaneously beating cardiac myocytes (Fig. 1).
Sympathetic synapses induce the formation 
of distinct plasma membrane signaling 
domains on cardiac myocyte membranes
Sympathetic synapses between cardiac myocytes and SGNs are 
unique cell–cell contacts designed for the effi  cient regulation of 
heart rate and contractility by the autonomic nervous system. 
The mechanism for the initiation and development of cardiac 
sympathetic synapses is not known. Cardiac myocytes do not 
express MuSK (Valenzuela et al., 1995), a key organizer of the 
postsynaptic zones in neuromuscular junctions, suggesting that 
sympathetic synapse formation does not involve agrin-MuSK 
signaling. One of the early events observed in our studies is the 
formation of cadherin–catenin complexes at the sites of contact 
between cardiac myocytes and SGN axons. Cadherins are 
known to form complexes with β-catenin, which, in turn, asso-
ciates with α-catenin and the actin cytoskeleton. There is a 
growing body of evidence that cadherin–catenin complexes 
function as signaling centers at neuronal synapses (Bamji et al., 
2003). We observed punctate immunostaining for both pancad-
herin and β-catenin on the surface of cardiac myocytes local-
ized along traces of axons (Figs. 5 A, 6, and S2). Synapsin I 
puncta were often observed overlapping cadherin and β-catenin 
immunostaining. These results suggest that cadherin–catenin 
complexes may be involved in stabilizing interactions between 
SGNs and myocytes; however, it is not possible to conclude that 
they play a more direct role in synaptic function.
A previous study provided evidence that the structure 
of cardiac sympathetic synapses is different from the neuromus-
cular junction and central nervous system synapses (Landis, 
1976). Using electron microscopy, Landis (1976) found that in a 
coculture of cardiac myocytes and SGNs, varicosities containing 
numerous synaptic vesicles were present along the length of 
contacting axons. These varicosities were seen 20–30 nm from 
the myocyte surface but also occurred at greater distances. 
Analysis of sympathetic and parasympathetic neuromuscular 
junctions in the guinea pig sinoatrial node revealed neuromus-
cular separations of  80 nm, which is greater than distances 
between pre- and postsynaptic membranes in central synapses 
(Choate et al., 1993). The limit of resolution by a two-photon 
microscope is  500 nm, which is considerably lower than what 
is necessary to estimate the distances between pre- and post-
synaptic membranes in our studies. Nevertheless, we observed 
Figure 9. SAP97  and  𝗃1ARs localize to cardiac sympathetic 
synapses in vitro. (A) Cardiac myocytes were cocultured with 
SGNs for 6 d, infected with recombinant adenovirus expressing 
HA-tagged β1AR, and cultured for an additional 24 h before 
immunostaining for HA (green) and SAP97 (red). Two-photon 
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that the postsynaptic cardiac myocyte membrane develops into 
specialized zones that invaginate to surround contacting axons. 
This can be seen in several 3D reconstructions of two-photon 
images (Figs. 8 E, 9 C, 10 C, and Video 1). The formation of this 
invagination in the myocyte membrane likely involves remodeling 
of the cytoskeleton, which might be controlled by cadherin–
catenin complexes that accumulate at sites of contact between 
SGNs and myocytes (Figs. 5 and 6). These specialized zones 
contain accumulations of β1ARs and the scaffold proteins 
SAP97 and AKAP79/150. The accumulation of scaffold com-
ponents AKAP79/150 and SAP97 at the postsynaptic zone in-
dicates the formation of a specifi  c signaling domain on the 
myocyte plasma membrane that may be required for physio-
logic signaling of ARs in cardiac tissue.
In contrast to SAP97 and AKAP79, caveolin-3 is dimin-
ished at sites of myocyte–neuron contact (Fig. 4). Caveolin-3 is 
a muscle-specifi  c marker of caveolae (a membrane subdomain) 
that is formed from lipid rafts by the polymerization of caveo-
lins, which are hairpinlike palmitoylated integral membrane 
proteins that bind cholesterol (Cohen et al., 2004). Caveolae are 
plasma membrane signaling domains that recruit certain lipid-
modifi  ed membrane proteins (including receptors, G   proteins, 
and tyrosine kinases) while excluding other proteins and lipid 
components (Cohen et al., 2004). These distinct plasma mem-
brane domains, synaptic and extrasynaptic, are likely to play 
important roles in distinguishing receptor signaling in response 
to catecholamines released from sympathetic nerve terminals 
(primarily norepinephrine) from catecholamines released 
from the adrenal gland (primarily epinephrine) and delivered 
by circulation.
Sympathetic synapses direct the distinct 
localization of 𝗃1 and 𝗃2ARs
Acute activation of cardiac βARs leads to an increase in heart 
rate and contractility and is an essential component of the phys-
iologic response to stress. However, prolonged activation of 
cardiac βARs by the sympathetic nervous system plays a key 
role in the pathogenesis of heart failure (Mann and Bristow, 
2005). Both β1 and β2ARs are expressed in the heart. These 
two AR subtypes are highly homologous both structurally and 
  functionally. However, these subtypes play distinct roles in 
 regulating normal cardiovascular physiology (Rohrer et al., 1999), 
and there is a growing body of evidence that they may play 
  opposing roles in the pathogenesis of heart failure (Patterson 
et al., 2004; Bernstein et al., 2005; Zheng et al., 2005). Our 
  current studies show that the subtype-specifi  c distribution of β1 
and  β2ARs relative to sympathetic synapses may contribute 
to the differences in signaling.
Synaptic localization of the 𝗃1AR. Accumula-
tion of β1ARs along with adhesion molecules, adaptor proteins, 
and signaling molecules suggests a highly organized signaling 
compartment designed for the most effi  cient transfer of infor-
mation from the SGN to the heart. The mechanism for the syn-
aptic localization of β1AR is not known. In the postsynaptic 
density of neuronal excitatory synapses, PDZ proteins organize 
receptors and their associated signaling proteins and determine 
the size and strength of synapses (Kim and Sheng, 2004). It has 
been shown that the C-terminal PDZ-binding motif of β1AR 
can bind directly to several PDZ domain–containing proteins, 
including PSD-95, MAGI-2, MAGI-3, ZO-1, GIPC, CAL, and 
SAP97 (He et al., 2006). Moreover, we have previously shown 
that disrupting the C-terminal PDZ-binding motif of β1AR dra-
matically alters its signaling in neonatal cardiac myocytes. The 
wild-type β1AR does not undergo agonist-induced internaliza-
tion in cardiac myocytes and signals only through Gs. In con-
trast, the β1AR-PDZ mutant internalizes upon agonist exposure 
and couples to both Gs and Gi (Xiang et al., 2002). Thus, PDZ 
domain interactions are important for normal β1AR function. 
Therefore, we were surprised to fi  nd that the synaptic localiza-
tion of β1AR was not disrupted by mutation of its C-terminal 
PDZ ligand (Fig. 9, C and D). However, for several postsynaptic 
receptors, including GluR2 (Osten et al., 2000; Chang and 
Rongo, 2005) and NMDARs (Migaud et al., 1998; Sprengel 
et al., 1998; Passafaro et al., 1999), it has been shown that 
synaptic localization is regulated through the sequences outside 
of the PDZ-binding motif.
Figure 10.  AKAP79/150 accumulates at cardiac sympathetic synapses 
in vitro. (A) Colocalization of AKAP79/150 and tyrosine hydroxylase. 
Cardiac myocytes and SGNs were cultured for 7 d and immunostained for 
tyrosine hydroxylase (red) and AKAP79/150 (green); two-photon image. 
(B) 3D-reconstructed enlarged fragment of the boxed area in A. (C) X-z 
cross section of the 3D reconstruction. (D) Colocalization of β1AR and 
AKAP79/150. Cardiac myocytes were cocultured with SGNs for 6 d, 
  infected with recombinant adenovirus expressing HA-tagged β1AR, and 
cultured for an additional 24 h before immunostaining for HA (red) and 
AKAP79/150 (green); two-photon image. (E) 3D-reconstructed enlarged 
fragment of the boxed area in D.JCB • VOLUME 176 • NUMBER 4 • 2007  530
It should be noted that we observed only partial colocal-
ization of β1AR with SAP97 and AKAP79/150 (Figs. 9 and 10). 
The partial overlap may represent physiologically relevant in-
teractions, or it may simply be a coincidence of having both 
proteins localized to the sympathetic synapse. β1AR is likely to 
be only one of several signaling membrane proteins (channels 
and receptors) at the sympathetic synapse. Sympathetic nerves 
also release ATP and neuropeptide Y, and the GPCRs recognizing 
these substances may also be localized to the synapse and could 
interact with SAP97 and AKAP79/150 in signaling domains 
that are distinct from the β1AR signaling compartment. Thus, 
SAP97 or AKAP79/150 may be involved in forming signaling 
compartments with several different GPCRs. It is also possible 
that we are saturating the β1AR signaling compartment with 
the recombinant adenoviral-expressed HA-tagged β1AR. This 
could explain why not all β1ARs localize with SAP97 and 
AKAP79/150.
Activity-dependent removal of 𝗃2ARs from 
the synaptic sites. In cocultures in which the SGNs were 
not stimulated by nicotine, β2ARs were uniformly distributed 
across the plasma membrane of the majority of myocytes. How-
ever, in a small percentage ( 2%) of myocytes, β2ARs are de-
pleted from zones in contact with neurons. Stimulation of 
neuronal activity by nicotine induced the rapid (within 5 min) 
removal of β2ARs from sites of contact in the majority of cells 
(72% cells; Fig. 7, E–H). The results indicate that β2AR is 
  removed from the sites of contact upon the release of neu-
rotransmitter from the SGN; thus, the depletion of β2ARs from 
synapses is dependent on neuronal activity. It has been well 
 established  that  β2ARs undergo agonist-induced internalization 
in cardiac myocytes (Xiang et al., 2002), and this is the most 
likely mechanism for the redistribution of β2AR after the activa-
tion of neurons by nicotine. This is consistent with the ability of 
the βAR antagonist alprenolol to inhibit the depletion of β2AR 
at sites of contact with SGN (Fig. S3).
Evidence from synaptotagmin uptake experiments sug-
gests that synapsin I puncta represent sites of synaptic vesicle 
release (Fig. 2). Therefore, it is somewhat surprising that β2AR 
depletion is observed along the entire axon (Fig. 7) and not 
just at synapsin I puncta. This may be caused by the diffusion 
of neurotransmitter between sites of synaptic vesicle release. 
Diffusion of neurotransmitter may be facilitated by the greater 
distance between pre- and postsynaptic membranes in neuro-
effector junctions of SGNs and cardiac myocytes compared 
with central nervous system synapses (Choate et al., 1993). It 
is also possible that β2ARs localized under SGNs are relatively 
mobile because of the lack of caveolin-3 (Fig. 4) or other 
  interacting proteins. As a result, during the 5 min of SGN stim-
ulation, noninternalized β2AR could diffuse to regions of 
  neurotransmitter release. Both explanations are consistent with 
the fi  nding that β2AR depletion was greater under synapsin I 
puncta compared with regions of the axon between synapsin I 
puncta (Fig. 7 H).
The redistribution of β2AR after the stimulation of neu-
rons suggests that this subtype may exhibit spatially and tem-
porally complex signaling behavior. The response of β2AR to 
noradrenaline released at synapses has to be temporally limited 
by internalization. β2ARs localized to extrasynaptic sites have 
limited exposure to high concentrations of norepinephrine but 
may still respond to epinephrine released from the adrenal gland 
into the circulation. Thus, the acute stimulation of β2ARs local-
ized in the sympathetic synapse may distinctly activate different 
signaling pathways than the activation of β2ARs associated with 
extrasynaptic caveolin-3 through circulating catecholamines.
Conclusion
We used cocultures of SGNs and cardiac myocytes to study the 
sympathetic synapse in vitro. We have shown that the sympa-
thetic innervation of cardiac myocytes is associated with the 
formation of distinct plasma membrane signaling domains that 
are enriched in cadherins, catenins, SAP97, AKAP79, and β1ARs 
and are depleted in caveolin-3. The β2ARs exhibit activity-
dependent dynamic behavior at the synaptic sites. The distinct 
plasma membrane domains are likely to play important roles in 
distinguishing receptor signaling in response to catecholamines 
released from sympathetic nerve terminals (predominantly nor-
epinephrine) from catecholamines released from the adrenal gland 
(predominantly epinephrine) and delivered by the circulation. 
A better understanding of the organization of these signaling 
complexes will be important for defi  ning the different roles 
played by these βAR subtypes in normal cardiovascular physi-
ology as well as in the pathogenesis of heart failure.
Materials and methods
Coculture of SGNs and neonatal mouse ventricular myocytes
SGNs were isolated from the cervical ganglia of newborn mouse pups by 
treating ganglia with collagenase type 1A-S (Sigma-Aldrich) and trypsin T 
XI (Sigma-Aldrich) followed by trituration. Neurons were plated on cover-
slips coated with laminin (Sigma-Aldrich) for immunocytometry as de-
scribed previously (Brum et al., 2006). Spontaneously beating neonatal 
cardiac myocytes were prepared from hearts of newborn mouse pups 
(from wild-type, β1AR KO, β2AR KO, and β1/β2AR KO mice) as described 
previously (Devic et al., 2001) and were added to already plated SGNs 
on the same day. After coculture for 24 h, cultures were treated with 1 μM 
cytosine arabinoside (Sigma-Aldrich) for 24 h to inhibit ﬁ  broblast growth. 
Cocultures were maintained in Leibovitz’s L-15 medium supplemented with 
Nu serum (BD Biosciences), NGF (Invitrogen), and ITS liquid media supple-
ment (Sigma-Aldrich). After cytosine arabinoside treatment, media were 
changed every 3 d as previously described (Brum et al., 2006).
Infection of cardiac myocytes with recombinant adenovirus 
Recombinant adenoviruses encoding HA-β1AR and FLAG-β2AR were pre-
pared as previously described (Xiang et al., 2002). Cocultures of cardiac 
myocytes and SGNs were infected with viruses at a multiplicity of infection 
of 100 at a desired time point (between 1–10 d in culture) and were ana-
lyzed 24–72 h later. SGNs are resistant to adenovirus infection, so primarily 
cardiac myocytes were infected.
Immunoﬂ  uoresence microscopy
Cocultures were ﬁ  xed by adding PBS (Mediatech, Inc.) containing 8% PFA 
directly to the culturing media to achieve a ﬁ  nal PFA concentration of 4%. 
Cells were permeabilized with 1% BSA solution in PBS containing 0.2% 
Triton X-100. Cells were then stained with the desired antibody. The anti-
bodies used were as follows: anti-FLAG M1 antibody (mouse monoclonal 
IgG2b; 1:600; Sigma-Aldrich), anti-HA 16b12 antibody (mouse mono-
clonal IgG1; 1:600; Covance; and rabbit polyclonal; 1:1,000; Berkeley 
Antibody Company), antisynapsin I (rabbit polyclonal; 1:1,000; Chemicon 
International), anti-SAP97 (mouse monoclonal; 1:250; StressGen Biotechnol-
ogies), anti–β-catenin (mouse monoclonal; 1:300; Transduction Laboratories), 
antipancadherin (mouse monoclonal; 1:500; Sigma-Aldrich), and antityrosine 
hydroxylase (rabbit polyclonal; 1:1,000; Chemicon International; and mouse 
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  antibody to the luminal domain of synaptotagmin I was a gift from P. Scheiffele 
(Columbia University, New York, NY). The primary antibodies were 
  detected with AlexaFluor594-conjugated goat anti–mouse IgG (1:1,000; 
Invitrogen) and AlexaFluor488 goat anti–rabbit IgG (1:1,000; Invitrogen). 
The slices for imaging were mounted with Vectashield mounting media 
(Vector Laboratories). The images were acquired at room temperature 
on an imaging microscope (Axioplan 2; Carl Zeiss MicroImaging, Inc.) 
  using a plan-Apochromat 63X 1.40 NA oil lens (Carl Zeiss MicroImaging, 
Inc.), a camera (RTE/CCD-1300-Y/HS; Roper Scientiﬁ  c), and IPLab soft-
ware (BD Biosciences). Confocal images were acquired using a confocal 
laser-scanning microscope (LSM510; Carl Zeiss MicroImaging, Inc.) 
equipped with a tunable Ti-Sapphire laser (Mira 900; Coherent) and a 
plan-Apo 63X 1.4 NA oil lens, and images were analyzed by Volocity 
software (Improvision).
Measurement of the spontaneous contraction rate of myocytes 
in the functional assay
Measurement of the spontaneous contraction rate was performed as 
  described previously (Devic et al., 2001) with some modiﬁ  cations. In brief, 
2–3  × 10
5 cardiac cells were cultured on the coverslips coated with 
  laminin (Sigma-Aldrich) and were placed in 35-mm petri dishes (Corning) 
to obtain a uniformly beating syncytium. SGNs were placed on the same 
coverslip or on a separate coverslip. On day 10–14, the culture dishes 
were placed in a temperature regulation apparatus positioned on the 
stage  of an inverted microscope (TMS; Nikon) connected to a video 
  camera (C2400-7; Hamamatsu). Cells were equilibrated at 37°C for 
10 min before monitoring the contraction rate. Contraction rates of cells 
within the syncytium were determined at 60-s intervals for 10 min before 
and 20 min after the stimulation of SGNs by 1 μM (−)nicotine hydrogen 
tartrate salt (Sigma-Aldrich). The data were analyzed using Prizm software 
(Prizm Software).
Stimulation of SGNs with nicotine
In experiments measuring the beat rate of myocytes cocultured with SGNs, 
1 μM nicotine ([−]nicotine hydrogen tartrate salt; Sigma-Aldrich) was used 
to avoid activation of the myocytes by outﬂ  ow of the released transmitter. 
In all other experiments, 500 μM nicotine was applied for 5 min followed 
by washout with prewarmed media.
Quantiﬁ  cation of 𝗃2AR removal from the sites of contact with SGNs
The Volocity program (Improvision) was used to quantify β2AR removal 
from the sites of contact between myocytes with SGNs. Mean ﬂ  uorescence 
intensity for the red channel representing immunostaining for FLAG-tagged 
β2AR was measured in areas where the green channel ﬂ  uorescence 
(immuno  staining for synapsin I) was selected as a criterion. Axonal areas 
where residual ﬂ  uorescence for green channel was present were included. 
Next, we excluded the area selected and measured the mean ﬂ  uorescence 
for the red channel at the extrasynaptic regions. Measurements were 
  performed in arbitrary units of a direct scale. Data were collected from 10 
images obtained in three experiments.
To compare the ﬂ  uorescence intensity of β2AR staining in the areas 
of synapsin I accumulation with areas along axons between synapsin I 
puncta, we used the Wizard tool of the Volocity program to select regions 
of interest. The data were obtained from three images using six different 
pairs of regions of interest on each image. Measurements were performed 
in arbitrary units of the direct scale. Statistic comparisons were performed 
with a t test. Statistical signiﬁ  cance was set as P < 0.05.
Comparison of the accumulation of 𝗃1AR in the zones of contact with SGNs
We used the histograms of ﬂ  uorescence intensity of the original LSM510 
ﬁ  les for ﬁ  ve different images to quantify the accumulation of β1AR in the 
zones of contact with SGNs. Mean ﬂ  uorescence intensity was quantiﬁ  ed in 
the areas inside and outside the zones of contact along the selected straight 
line crossing a zone of contact (Fig. 8 B; two zones from each image). 
Measurements were performed in arbitrary units of the direct scale. Statistic 
comparisons were performed with a t test. Statistical signiﬁ  cance was set 
as P < 0.05.
Colocalization of pancadherin immunostaining with synapsin I
Colocalization of pancadherin immunostaining with synapsin I was quanti-
ﬁ  ed using the Volocity program (Improvision). Cadherin puncta were de-
ﬁ   ned as discrete areas where ﬂ   uorescence intensity was higher than 
threshold ﬂ  uorescence in areas outside the sites of contacts. We ﬁ  rst mea-
sured the total number of cadherin puncta and then measured the number 
of puncta that had colocalization with synapsin puncta. The percentage of 
colocalizing puncta was collected from seven images. Analogously, we 
measured the total number of synapsin puncta and the number of synapsin 
puncta that had overlap with cadherin puncta.
FM1-43 imaging
All chemicals were purchased from Sigma-Aldrich unless mentioned other-
wise. Cells were cultured on microscopy coverglass (Glaswarenfabrik Karl 
Hecht KG). After 7 d in culture, cocultures were transferred from medium to 
an imaging chamber containing 400 μl Tyrode (150 mM NaCl, 4 mM 
KCl, 2 mM CaCl2, 2 mM MgCl2, 10 mM Hepes, 10 mM glucose, pH 7.35; 
310 osmol) supplied with 25 μg/ml NGF (Invitrogen). After mounting on 
a microscope (TE-200; Nikon), another 400 μl Tyrode containing 1 mM 
nicotine tartrate and 10 μM FM1-43 was added (load). After a 2-min 
  incubation at room temperature, cells were perfused with the original 
Tyrode containing 0.1 mM ADVASEP-7 (CyDex, Inc.) at a speed of 1 ml/s 
for  7 min to wash out FM1-43 remaining on the plasma membrane. The 
destaining protocol (unload) during the imaging period was as follow: 
Tyrode for 30 s, 500 μM nicotine in Tyrode for 120 s, and Tyrode for 60 s.
Fluorescence detection of FM1-43 signals was performed using an 
inverted epiﬂ   uorescence microscope (TE-200; Nikon) equipped with a 
plan Fluor 40X 1.3 NA objective (Nikon). Images were obtained with an 
intensiﬁ  ed CCD camera (XR/Mega-10; Stanford Photonics) operating in 
gated acquisition mode. The samples were exposed to brief pulses of arc 
lamp illumination (470/40 nm; Chroma Technology Corp.) via an optical 
switch (Lambda 10-2; Sutter Instrument Co.). The emission signal was ﬁ  l-
tered by a 515-nm long-pass optical ﬁ  lter (Chroma Technology Corp.). The 
imaging rate was 1 Hz, and the exposure time was 30 ms with intensiﬁ  er 
gain at 900 V. Images were downloaded in a 10-bit digital format (MV-
1465; mTech) and processed with MetaFluor (MicroDevice). Off-line analy-
sis was performed with ImageJ (National Institutes of Health) and Excel 
software (Microsoft). The data were plotted by SigmaPlot (Systat Software). 
Each point represents the mean of a total of 55 puncta chosen on a surface 
of cardiac myocytes from two different cocultures. We normalized ﬂ  uores-
cence intensity change within the range of 0 to 1 for each experiment. In 
addition, regression ﬁ  tting was used to offset the photobleaching effect. In 
detail, the ﬂ  uorescent signal from the images, which was taken during the 
ﬁ  rst 30 s of Tyrode perfusion, was used to generate an exponential decay 
function. This function was then used to correct the photobleaching of the 
ﬁ  rst 30-s image such that a steady baseline could be established, and its 
mean ﬂ  uorescence intensity value was deﬁ  ned as 1. Similarly, the very last 
60-s images were used to generate an exponential decay function, which 
was used to establish a steady baseline (deﬁ  ned as 0). The ﬂ  uorescence in-
tensity change in between was then subjected to regression ﬁ  tting based 
on the two deﬁ  ned exponential decays and was normalized by the deﬁ  ned 
1 and 0 baselines.
Immunostaining of mouse cardiac sections
Mice were killed, and hearts were removed and placed in cold PBS buffer. 
The hearts were rinsed in buffer, cut into halves, and ﬁ  xed in cold PBS con-
taining 4% PFA for 24 h at 4°C. 50–70-μM slices were cut by a sectioning 
system (Series 1000; Vibratome) and incubated in blocking solution for 1 h 
followed by immunostaining. Imaging was performed by two-photon 
microscopy using 0.3-μM slices. 3D reconstruction was performed using 
Volocity software (Improvision).
Detection of synaptic activity by uptake of the antibody to the luminal 
domain of synaptotagmin
The antibody to the luminal domain of synaptotagmin (rabbit polyclonal) 
was a gift from P. Scheiffele. Cocultures of cardiac myocytes and SGNs 
were incubated with serum-free media containing 500 μM nicotine and 
10 μg/ml synaptotagmin antibody for 15 min followed by washout with 
prewarmed complete media. Cells were then ﬁ  xed and stained with mouse 
monoclonal to synapsin I.
Online supplemental material
Fig. S1 shows uptake and release of the ﬂ  uorescent dye FM1-43 by sym-
pathetic neurons innervating cardiac myocytes. Fig. S2 shows immuno-
staining for β-catenin and synapsin I in the mouse heart. Fig. S3 shows the 
effect of a β blocker on the removal of β2AR from sympathetic synapses. It 
demonstrates that the pretreatment of coculture with a β blocker abolishes 
the activity-dependent removal of β2AR from synaptic sites. Fig. S4 shows 
the increase of SAP97 accumulation at the synaptic sites after 90 min of 
stimulation with nicotine in cocultures in which β1AR was overexpressed in 
cardiac myocytes. Fig. S5 shows immunostaining for SAP97 and synapsin I 
in the mouse heart. Video 1 shows the rotation of the 3D-reconstructed JCB • VOLUME 176 • NUMBER 4 • 2007  532
  image in Fig. 8 E. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200604167/DC1.
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